Trial intelligence / Profile preview

Entoban vs Metronidazole for Chronic Diarrhea

NCT02642250Phase 3Completed

Sponsor
Shifa-ul-Mulk Memorial Hospital
Start
Jan 2015
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sulfaguanidine + phthalylsulfathiazole + streptomycin + activated charcoal in Chronic diarrhea, sponsored by Shifa-ul-Mulk Memorial Hospital. Started Jan 2015; status: completed.

02

Drugs

sulfaguanidine + phthalylsulfathiazole + streptomycin + activated charcoal
03

Conditions

Chronic diarrhea

Beyond the preview

Go deeper on NCT02642250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02642250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call